GNRH-AGONIST CO-TREATMENT DURING CHEMOTHERAPY FOR THE PRESERVATION OF OVARIAN FUNCTION: A META-ANALYSIS.

被引：1
|
作者：
Gharwan, H. [1 ]
Wilkerson, J. [1 ]
Fojo, A. T. [1 ]
机构：
[1] NCI, Bethesda, MD 20892 USA
来源：
FERTILITY AND STERILITY | 2014年 / 102卷 / 03期
关键词：
D O I：
10.1016/j.fertnstert.2014.07.544
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
P-59
引用
收藏
页码：E159 / E159
页数：1
相关论文
共 50 条
  • [41] Is letrozole during ovarian stimulation useful in breast cancer patients undergoing fertility preservation to reduce early luteal progesterone levels following GnRH-agonist trigger?
    Imane Lalami
    Julie Labrosse
    Isabelle Cedrin-Durnerin
    Marjorie Comtet
    Claire Vinolas
    Fabien Krief
    Christophe Sifer
    Maeliss Peigne
    Michael Grynberg
    Reproductive Biology and Endocrinology, 20
  • [42] Circulating osteoprotegerin in women during GnRH-agonist treatment and their relationships with mineral components and biomarkers of bone turnover
    Uemura, H
    Yasui, T
    Umino, Y
    Niki, H
    Takikawa, M
    Saito, S
    Furumoto, H
    Irahara, M
    BONE, 2003, 33 (05) : 860 - 866
  • [43] Gonadotropin-Releasing Hormone Agonist for Preservation of Ovarian Function During (Neo)Adjuvant Chemotherapy for Breast Cancer
    Blumenfeld, Zeev
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (26) : 3310 - 3310
  • [44] GnRH antagonist and letrozole co-treatment in diminished ovarian reserve patients: a proof-of-concept study
    Olgan, Safak
    Humaidan, Peter
    REPRODUCTIVE BIOLOGY, 2017, 17 (01) : 105 - 110
  • [45] Molecular Evidence Against Ovarian Protection with the Co-Administration of GNRH Agonist with Chemotherapy in Human.
    Bildik, Gamze
    Akin, Nazli
    Senbabaoglu, Filiz
    Selek, Ugur
    Iwase, Akira
    Oktem, Ozgur
    REPRODUCTIVE SCIENCES, 2016, 23 : 343A - 343A
  • [46] Gonadotropin-Releasing Hormone Analog Cotreatment for the Preservation of Ovarian Function during Gonadotoxic Chemotherapy for Breast Cancer: A Meta-Analysis
    Wang, Chuan
    Chen, Minyan
    Fu, Fangmeng
    Huang, Meng
    PLOS ONE, 2013, 8 (06):
  • [47] Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function during gonadotoxic chemotherapy: a systematic review and meta-analysis
    Bedaiwy, Mohamed A.
    Abou-Setta, Ahmed M.
    Desai, Nina
    Hurd, William
    Starks, David
    El-Nashar, Sherif A.
    Al-Inany, Hesham G.
    Falcone, Tommaso
    FERTILITY AND STERILITY, 2011, 95 (03) : 906 - U94
  • [48] OVARIAN FOLLICULAR GROWTH AND DEVELOPMENT IN HEIFERS DURING AND SUBSEQUENT TO CHRONIC TREATMENT WITH A GnRH AGONIST
    Braga, D. P. A. F.
    Irving-Rodgers, H.
    Baruselli, P. S.
    Aspden, W. J.
    Borges, E., Jr.
    D'Occhio, M. J.
    FERTILITY AND STERILITY, 2013, 100 (03) : S323 - S323
  • [49] Protection of ovarian function and fertility using a combination of gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist during cancer treatment in young females
    Potolog-Nahari, Claris
    Fishman, Ami
    Cohen, Ilan
    GYNECOLOGICAL ENDOCRINOLOGY, 2007, 23 (05) : 290 - 294
  • [50] The oncologic effect of a gonadotropin releasing hormone (GnRH) agonist for ovarian protection during breast cancer chemotherapy
    Kim, H. J.
    Lee, M. H.
    Lee, J. E.
    Park, S. H.
    Lee, E. S.
    Kang, Y-J
    Lee, J. H.
    Shin, H. N.
    Kim, S. I.
    Im, S. A.
    Ahn, S. H.
    Lee, K. S.
    Sohn, J.
    Han, W.
    Nam, S. J.
    CANCER RESEARCH, 2016, 76
12345